SGMO
SGMO
NASDAQ · Biotechnology

Sangamo Therapeutics Inc

$0.14
0.00 (-0.37%)
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +14,929.6% upside
Low Target $11.90
Average Target $20.29
High Target $29.33
Current Price $0.14
Current
$0.14
Target
$20.29
$11.90 $20.29 avg $29.33
Scenario Analysis
Bear Case
$11.90
8,714.8%
Low target
Base Case
$20.29
+14,929.6%
Avg target
Bull Case
$29.33
+21,625.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$0.77
-82.4% from high
52-Week Low
$0.10
+35.0% from low
Target vs 52W High
$20.29
+2,548.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +20.5%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.2%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +178.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.1%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -88.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -23.9%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.0%